GFA
PFE icon

Gallagher Fiduciary Advisors’s Pfizer PFE Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-77,700
Closed -$3.11K – 218
2023
Q1 		$3.11K Buy
+77,700
New +$3.36M ﹤0.01% 200

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Gallagher Fiduciary Advisors's PFE Position: Q2 2026 in Review

Gallagher Fiduciary Advisors increased its Pfizer (PFE) stake by 4.3% in Q2 2026, buying an estimated $32.3K and bringing the position to 30,148 shares worth $726K. The position accounts for 0.02% of the portfolio, ranked #143.

Gallagher Fiduciary Advisors first reported a position in PFE in Q4 2014 and has held it in 16 quarters since. The position peaked at $102M in Q4 2014. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Gallagher Fiduciary Advisors held 30,148 shares of Pfizer worth $726K as of Q2 2026.
  • Gallagher Fiduciary Advisors bought 1,235 Pfizer shares in Q2 2026, an estimated $32.3K.
  • Pfizer made up 0.02% of Gallagher Fiduciary Advisors's portfolio in Q2 2026, its #143 holding.
  • Gallagher Fiduciary Advisors first reported a position in Pfizer in Q4 2014 and has held it in 16 quarters since.
  • Gallagher Fiduciary Advisors's Pfizer position peaked at $102M in Q4 2014.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.